| Both sides previous revisionPrevious revisionNext revision | Previous revision |
| hair_analyses_ext [2026/11/10 08:28] – laura | hair_analyses_ext [2026/11/10 08:32] (current) – [Table] laura |
|---|
| |
| ===== Study overview ===== | ===== Study overview ===== |
| The table below provides you with the most relevant points for each project. Details of the available variables are provided separately on [[urine ext variables|this page]]. | The table below provides you with the most relevant points for each project. Details of the available variables are provided below. |
| |
| It is important to note that the assessment rounds indicate when the urine samples were collected, rather than when the laboratory analyses were performed. While FDI refers to form description of instrument or method. | It is important to note that the assessment rounds indicate when the urine samples were collected, rather than when the laboratory analyses were performed. While FDI refers to form description of instrument or method. |
| |
| | **Project code** | **Requesting institution** | **Performing laboratory** | **Participant selection (incl. N)** | **Assessment** | **Data availability** | **FDI** | **Publication** | | | **Project code** | **Requesting institution** | **Performing laboratory** | **Participant selection (incl. N)** | **Assessment** | **Data availability** | **FDI** | **Publication** | |
| | | | | //in 10-20 woorden (N ~XXX)// | //[[1A]] / [[2A]] / [[3A]]// | //Available / Under embargo / Unavailable// | //Available / Pending / Unavailable// | //Submitted / Naam jaar met DOI eronder / Unavailable// | | | | | | //in 10-20 woorden (N ~XXX)// | //[[1A]] / [[2A]] / [[3A]]// | //Available / Under embargo / Unavailable// | //Available / Pending / Unavailable// | //Submitted / Naam jaar met DOI eronder / Unavailable// | |
| | OV18_0427 | VUMC | UMCG | matched controls for childhood cancer survivers (N~500) | [[1A]] | Available | Unavailable | [[https://doi.org/10.3390/cancers14112754|Kooijmans et al. (2022)]] | | | OV18_0427 | VUMC | UMCG | matched controls for childhood cancer survivers (N~500) | [[1A]] | Available | Unavailable | [[https://doi.org/10.3390/cancers14112754|Kooijmans et al. (2022)]] | |
| | | OV17_0374 | Erasmus MC | | | | | | | |
| |
| ===== Variables ===== | ===== Variables ===== |
| | **Project code** | **Sample type** | **Label English** | **Label Dutch** | **Code** | **Variable** | **Assessment** | **Availability** | | | **Project code** | **Sample type** | **Label English** | **Label Dutch** | **Code** | **Variable** | **Assessment** | **Availability** | |
| | OV18_0427 | Early morning | alpha-1-microglobulin in early morning spot urine (mg/l) | alpha-1-microglobuline in eerst geloosde ochtendurine (mg/l) | urems_a1microglobulin _all_m_1 | a1mu_mgl | [[1A]] | Available | | | OV18_0427 | Early morning | alpha-1-microglobulin in early morning spot urine (mg/l) | alpha-1-microglobuline in eerst geloosde ochtendurine (mg/l) | urems_a1microglobulin _all_m_1 | a1mu_mgl | [[1A]] | Available | |
